PMC Links for Books (Select 4862292) - PMC

Select item 106973961.

Subgroup Analysis of US and Non-US Patients in a Global Study of High-Dose Donepezil (23 mg) in Moderate and Severe Alzheimer’s Disease

Stephen Salloway, Jacobo Mintzer, Jeffrey L. Cummings, David Geldmacher, Yijun Sun, Jane Yardley, Joan Mackell

Am J Alzheimers Dis Other Demen. 2012 Sep; 27(6): 421–432. Published online 2012 Aug 28. doi: 10.1177/1533317512454708

PMCID:: PMC10697396

Abstract Article PDF–514K

Select item 69447122.

Comparison of cholinesterase inhibitor safety in real-world practice

Greg Carney, Ken Bassett, James M. Wright, Malcolm Maclure, Nicolette McGuire, Colin R. Dormuth

Alzheimers Dement (N Y) 2019; 5: 732–739. Published online 2019 Nov 25. doi: 10.1016/j.trci.2019.09.011

PMCID:: PMC6944712

Abstract Article PDF–287K

Select item 66260653.

Alzheimer's disease medication and risk of all-cause mortality and all-cause hospitalization: A retrospective cohort study

Sandipan Bhattacharjee, Asad E. Patanwala, Wei-Hsuan Lo-Ciganic, Daniel C. Malone, Jeannie K. Lee, Shannon M. Knapp, Terri Warholak, William J. Burke

Alzheimers Dement (N Y) 2019; 5: 294–302. Published online 2019 Jul 10. doi: 10.1016/j.trci.2019.05.005

PMCID:: PMC6626065

Abstract Article PDF–477K

Select item 65295344.

Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease

Dan-Dan Li, Ya-Hong Zhang, Wei Zhang, Pu Zhao

Front Neurosci. 2019; 13: 472. Published online 2019 May 15. doi: 10.3389/fnins.2019.00472

PMCID:: PMC6529534

Abstract Article PDF–4.1M

Select item 64923905.

Safety and tolerability of donepezil 23 mg with or without intermediate dose titration in patients with Alzheimer’s disease taking donepezil 10 mg: a multicenter, randomized, open-label, parallel-design, three-arm, prospective trial

Yun Jeong Hong, Hyun Jeong Han, Young Chul Youn, Kyung Won Park, Dong Won Yang, SangYun Kim, Hwa Jung Kim, Ji Eun Kim, Jae-Hong Lee, on behalf of the ODESA study (Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23 mg)

Alzheimers Res Ther. 2019; 11: 37. Published online 2019 May 1. doi: 10.1186/s13195-019-0492-1

PMCID:: PMC6492390

Abstract Article PDF–1003K

Select item 63090836.

Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer’s disease: a network meta-analysis of 41 randomized controlled trials

Kai-Xin Dou, Meng-Shan Tan, Chen-Chen Tan, Xi-Peng Cao, Xiao-He Hou, Qi-Hao Guo, Lan Tan, Vincent Mok, Jin-Tai Yu

Alzheimers Res Ther. 2018; 10: 126. Published online 2018 Dec 27. doi: 10.1186/s13195-018-0457-9

PMCID:: PMC6309083

Abstract Article PDF–1.6M

Select item 58108547.

An update on the safety of current therapies for Alzheimer’s disease: focus on rivastigmine

Rita Khoury, Jayashree Rajamanickam, George T. Grossberg

Ther Adv Drug Saf. 2018 Mar; 9(3): 171–178. Published online 2018 Jan 8. doi: 10.1177/2042098617750555

PMCID:: PMC5810854

Abstract Article PDF–418K

Select item 44462358.

Features and Outcomes of 899 Patients with Drug-induced Liver Injury: The DILIN Prospective Study

N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, KR Reddy, PB Watkins, V Navarro, H Barnhart, J Gu, J Serrano, for the United States Drug Induced Liver Injury Network

Gastroenterology. Author manuscript; available in PMC 2016 Jun 1.

Published in final edited form as: Gastroenterology. 2015 Jun; 148(7): 1340–1352.e7. Published online 2015 Mar 6. doi: 10.1053/j.gastro.2015.03.006

PMCID:: PMC4446235

Abstract Article PDF–546K

Select item 43385659.

Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial

Manabu Ikeda, Etsuro Mori, Kazutaka Matsuo, Masaki Nakagawa, Kenji Kosaka

Alzheimers Res Ther. 2015; 7: 4. Published online 2015 Feb 3. doi: 10.1186/s13195-014-0083-0

PMCID:: PMC4338565

Abstract Article PDF–630K

Select item 399225010.

Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study

Adrian Reuben, David G. Koch, William M. Lee, the Acute Liver Failure Study Group

Hepatology. Author manuscript; available in PMC 2014 Apr 20.

Published in final edited form as: Hepatology. 2010 Dec; 52(6): 2065–2076. Published online 2010 Oct 14. doi: 10.1002/hep.23937

PMCID:: PMC3992250

Abstract Article PDF–328K

Select item 382634411.

Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis

Andrea C. Tricco, Charlene Soobiah, Shirra Berliner, Joanne M. Ho, Carmen H. Ng, Huda M. Ashoor, Maggie H. Chen, Brenda Hemmelgarn, Sharon E. Straus

CMAJ. 2013 Nov 5; 185(16): 1393–1401. doi: 10.1503/cmaj.130451

PMCID:: PMC3826344

Abstract Article PDF–297K

Select item 365424412.

Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

Naga Chalasani, Robert J. Fontana, Herbert L. Bonkovsky, Paul B. Watkins, Timothy Davern, Jose Serrano, Hongqiu Yang, James Rochon, for the Drug Induced Liver Injury Network (DILIN)

Gastroenterology. Author manuscript; available in PMC 2013 May 15.

Published in final edited form as: Gastroenterology. 2008 Dec; 135(6): 1924–1934.e4. Published online 2008 Sep 17. doi: 10.1053/j.gastro.2008.09.011

PMCID:: PMC3654244

Abstract Article PDF–96K

Select item 349332813.

Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease

Pierre Tariot, Steven Salloway, Jane Yardley, Joan Mackell, Margaret Moline

BMC Res Notes. 2012; 5: 283. Published online 2012 Jun 8. doi: 10.1186/1756-0500-5-283

PMCID:: PMC3493328

Abstract Article PDF–194K

Select item 312670514.

Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease

Martin Farlow, Felix Veloso, Margaret Moline, Jane Yardley, Elimor Brand-Schieber, Francesco Bibbiani, Heng Zou, Timothy Hsu, Andrew Satlin

BMC Neurol. 2011; 11: 57. Published online 2011 May 25. doi: 10.1186/1471-2377-11-57

PMCID:: PMC3126705

Abstract Article PDF–240K

Select item 254646615.

Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis

Richard A Hansen, Gerald Gartlehner, Aaron P Webb, Laura C Morgan, Charity G Moore, Daniel E Jonas

Clin Interv Aging. 2008 Jun; 3(2): 211–225. Published online 2008 Jun.

PMCID:: PMC2546466

Abstract Article PDF–155K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 15

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity